Serum miRNAs in women affected by hyperandrogenic polycystic ovary syndrome: the potential role of miR-155 as a biomarker for monitoring the estroprogestinic treatment-Reference-Cited by-同舟云学术

Serum miRNAs in women affected by hyperandrogenic polycystic ovary syndrome: the potential role of miR-155 as a biomarker for monitoring the estroprogestinic treatment

Published:2018-01-31 Issue:8 Volume:34 Page:704-708
ISSN:0951-3590
Container-title:Gynecological Endocrinology
language:en
Short-container-title:Gynecological Endocrinology

Author:

Arancio Walter¹^ORCID,Calogero Amato Marco¹,Magliozzo Miriam¹,Pizzolanti Giuseppe¹,Vesco Rosalia¹,Giordano Carla¹

Affiliation:

1. Section of Endocrinology, Diabetes and Metabolism, Biomedical Department of Internal and Specialized Medicine (Di.Bi.M.I.S), University of Palermo, Palermo, Italy

Funder

FESR PON

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.1080/09513590.2018.1428299

Reference40 articles.

1. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria

2. Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline

3. Insulin resistance and polycystic ovary syndrome